Tempus AI offers $350 million in notes, aiming to cut debt costs

Tempus AI announced a private placement of $350 million in convertible senior notes due 2032.

The company intends to use net proceeds to repay $307.7 million in existing loans.

This strategy aims to reduce interest expenses and enhance financial flexibility.

Remaining capital will fund general operations and capped call transactions to limit shareholder dilution.

The move follows May 5 results reporting a 36.1% year-over-year revenue increase.

Tempus also reported a wider-than-expected GAAP loss per share for the first quarter.

Analysts highlighted strong oncology testing results but noted decelerating revenue growth.